Physician profile
Chelsy E Moore
NPI 1437780715
$3,314.95
in general payments reported to CMS, 2019-2025
32 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $881 · 2022: $1,041 · 2023: $565 · 2024: $664 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,393.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $520.44 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $402.59 | 2022-2024 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $336.91 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $236.70 | 2023-2025 | |
| Lilly USA, LLC | $206.45 | 2021-2023 | Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $194.29 | 2021-2024 | |
| Abbvie INC. | $156.57 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.20 | 2021-2023 | Stiolto Respimat |
| Pfizer INC. | $150.19 | 2021-2024 | |
| Boston Scientific Corporation | $134.36 | 2022-2025 | Resonate El Icd Vr, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $102.51 | 2023-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $95.17 | 2021-2022 | |
| Amgen INC. | $73.50 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $70.43 | 2022-2023 | Xarelto |
| Ultragenyx Pharmaceutical INC. | $63.23 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $44.50 | 2021-2024 | Gardasil, Gardasil 9, Capvaxive |
| Teva Pharmaceuticals USA, INC. | $41.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $34.51 | 2021-2022 | |
| Edwards Lifesciences Corporation | $33.54 | 2025 | |
| Dexcom, INC. | $32.01 | 2021-2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $28.38 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $21.55 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.99 | 2024-2025 | Lifevest |
| Xeris Pharmaceuticals, INC. | $20.81 | 2022 | |
| Axonics, INC. | $20.39 | 2024 | Axonics, Bulkamid |
| Exact Sciences Corporation | $20.38 | 2023 | Cologuard Collection Kit |
| Abiomed | $18.45 | 2024 | Impella |
| Lantheus Medical Imaging, INC. | $18.32 | 2024 | |
| Vifor Pharma, INC. | $15.80 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.43 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.16 | 2022 | |
| Philips North America LLC | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsy Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.